Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Sell Rubicon Technology, Inc. (RBCN)?

Page 1 of 2

What’s a smart Rubicon Technology, Inc. (NASDAQ:RBCN) investor to do?

In today’s marketplace, there are a multitude of gauges shareholders can use to watch the equity markets. Some of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best investment managers can outperform the S&P 500 by a superb margin (see just how much).

Just as useful, bullish insider trading activity is another way to analyze the world of equities. Just as you’d expect, there are plenty of reasons for a corporate insider to drop shares of his or her company, but only one, very clear reason why they would buy. Several academic studies have demonstrated the market-beating potential of this tactic if you know what to do (learn more here).

Rubicon Technology, Inc. (NASDAQ:RBCN)

What’s more, let’s study the recent info surrounding Rubicon Technology, Inc. (NASDAQ:RBCN).

Hedge fund activity in Rubicon Technology, Inc. (NASDAQ:RBCN)

At Q2’s end, a total of 7 of the hedge funds we track held long positions in this stock, a change of 0% from one quarter earlier. With the smart money’s positions undergoing their usual ebb and flow, there exists a select group of key hedge fund managers who were increasing their stakes substantially.

Out of the hedge funds we follow, Royce & Associates, managed by Chuck Royce, holds the biggest position in Rubicon Technology, Inc. (NASDAQ:RBCN). Royce & Associates has a $12.9 million position in the stock, comprising less than 0.1%% of its 13F portfolio. Coming in second is Ariel Investments, managed by John W. Rogers, which held a $11.3 million position; 0.2% of its 13F portfolio is allocated to the stock. Other hedge funds that are bullish include John Burbank’s Passport Capital, Gregory A. Weaver’s Invicta Capital Management and Matthew Hulsizer’s PEAK6 Capital Management.

Judging by the fact that Rubicon Technology, Inc. (NASDAQ:RBCN) has faced a fall in interest from upper-tier hedge fund managers, logic holds that there is a sect of hedgies who were dropping their positions entirely heading into Q2. Intriguingly, Christopher Zepf and Brian Thonn’s Kingdom Ridge Capital cut the largest position of the “upper crust” of funds we watch, worth close to $1.7 million in stock. Jim Simons’s fund, Renaissance Technologies, also dumped its stock, about $0.2 million worth. These bearish behaviors are important to note, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

What do corporate executives and insiders think about Rubicon Technology, Inc. (NASDAQ:RBCN)?

Bullish insider trading is at its handiest when the company in focus has seen transactions within the past half-year. Over the latest half-year time period, Rubicon Technology, Inc. (NASDAQ:RBCN) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Rubicon Technology, Inc. (NASDAQ:RBCN). These stocks are MaxLinear, Inc. (NYSE:MXL), Ultra Clean Holdings Inc (NASDAQ:UCTT), Actions Semiconductor Co., Ltd. (ADR) (NASDAQ:ACTS), Sigma Designs Inc (NASDAQ:SIGM), and Canadian Solar Inc. (NASDAQ:CSIQ). This group of stocks belong to the semiconductor – specialized industry and their market caps are closest to RBCN’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!